Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2021
A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severityZigui Chen, Ka Chun Chong, Martin C S Wong, et al.
Infectious Disease Modelling|July 13, 2023
Impact of climate change on dengue fever epidemics in South and Southeast Asian settings: A modelling studyYawen Wang, Shi Zhao, Yuchen Wei, et al.
The Journal of Infection|January 10, 2016
Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm in Southern China: A serial cross-sectional studyChunli Wu, Maggie Haitian Wang, Xing Lu, et al.
BMC Public Health|June 27, 2021
Long-term effectiveness of elderly health care voucher scheme strategies: a system dynamics simulation analysisKa Chun Chong, Hong Fung, Carrie Ho Kwan Yam, et al.
Journal of Global Health|October 12, 2023
Relationship between temperature variability and daily hospitalisations in Hong Kong over two decadesKehang Li, Yawen Wang, Xiaoting Jiang, et al.
Computational and Structural Biotechnology Journal|September 6, 2021
Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: A systematic reviewJingxuan Wang, Xiao Chen, Zihao Guo, et al.
Environmental Pollution (Barking, Essex : 1987)|November 11, 2021
Association of weather, air pollutants, and seasonal influenza with chronic obstructive pulmonary disease hospitalization risksKa Chun Chong, Yu Chen, Emily Ying Yang Chan, et al.
Epidemics|January 29, 2023
A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemicZihao Guo, Shi Zhao, Shui Shan Lee, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2024
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional boosterYun Sang Tang, Chee Wah Tan, Ka Chun Chong, et al.
Pageof 13